Tonix Pharmaceuticals Holding Corp.
NASDAQ: TNXP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Seth Lederman
- Employees
- 81
- Headquarters
- Chatham, United States
- IPO year
- 2012
- Market cap
- $192.9M
- Website
- https://www.tonixpharma.com
Loading TNXP…
Loading profile data…Frequently asked questions about TNXP
What does Tonix Pharmaceuticals Holding Corp. (TNXP) do?
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical firm primarily operating in the clinical development stage. Its overarching mission involves the discovery, acquisition, advancement, and commercialization of novel therapeutic agents and diagnostic tools, all aimed at combating human illnesses and easing patient discomfort. The company...
Where does TNXP trade?
Tonix Pharmaceuticals Holding Corp. (TNXP) trades on the NASDAQ Capital Market.
What sector is TNXP in?
Tonix Pharmaceuticals Holding Corp. (TNXP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Tonix Pharmaceuticals Holding Corp.?
Seth Lederman is the chief executive officer of Tonix Pharmaceuticals Holding Corp. (TNXP).
Where is Tonix Pharmaceuticals Holding Corp. headquartered?
Tonix Pharmaceuticals Holding Corp. is headquartered in United States.
Does TNXP pay a dividend?
Tonix Pharmaceuticals Holding Corp. (TNXP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TNXP go public?
Tonix Pharmaceuticals Holding Corp. (TNXP) completed its initial public offering in 2012.